Top Banner
Proliferating Cells of Human Basal Cell Carcinoma Are Located on the Periphery of Tumor Nodules Ronald E. Grimwood, M.D. , Charles F. Ferris, Ph .D ., Don ald B . Mcr cill, B.S., and J. C lark Huff , M. D . De pa rtm e nt of I c rmat o lo gy . Uni versity of Co lo rad o (J C I-1) , Denve r, Co lorado; I cpa rtmcn ts of Medi cin e and Clini c: 1l In ves tigation, Fit zs imons Arm y Medi ca l Ce nt er (C FF , DBM) , Aurora, Co lorado; and Depa rtm e nt of Med ic ine, O hio State Uni ve rsity (REG), Co lumbu s, O hi o, U. S. A. S tudy of th e g rowth c hara cte ri s ti cs o f ba sa l ce ll car cino ma ( BCC), a relativ e ly we ll- org ani zed, s low- g rowin g s kin ca nc er, ha s b ee n limit ed b ec au se of th e lack of me thod s fo r propa g ation of th e tum or off the human ho s t. We ha ve us ed ne wl y d ev elo ped t ec hniqu es for tr anspla ntati on and propa g ation of B CC on a th y mi c mi ce to s tudy e HJthymidine in corpor a tion by no dubr DC C. In human BC Cs lab e led in vitro imme di ately a fter removal from th e mic e and in vivo on th e mi ce , [ 3 Hjth y midin e durin g a 4- B asal ce ll ca rcin om as (B CCs) acco unt for at least 75% of cancer of the skin, the most co mm on sit . e o f hum an can cers, and thus are the most comm on clini ca l-hi s- to l og ic subset o fhuman mali g nan cies f I ,2]. Although not a cause of significant mo rt ality, B CC do es ac- count for considerable morbidity and fo r sig nifi ca nt expenditur es of h ealth ca re dollars. S tud y o fB CC has been ha mp ered by the difficulti es of study in g a ca ncer on the hum an host, the lack of an a nim al model, and th e in ability to pr o pa gate the tum or in virro. In particular, it ha s no t been possible to und erstand the gro wth clura cte ri s ti cs of this us ually well-organized, slow ly inv as ive, but hi stolog icall y ma- lig na nt tum o r. Pre vi ously reported att e mpt s to pe rf orm aut ora- di og raphic studies of human BCC have not prese nt ed data that wo uld loca li ze the prolif erating ce ll s to a particular a na to mi c ar ea of the B CC tumor [3-5]. We hav e recently described me thod s by which hum an BCC may be prop ag ated on the athymic or nude mouse and have sh ow n that B CC g rowin g on the mouse maint a in s th e hi stology ofB CC on the human host [6]. We also noted as part of o ur pil o t stu di es of 4 tum ors that [ 3 H ]thymidine uptake by BCC harvested fro m the nude mou se w as not unif orm thr oughout the tum or but was predo minantly localize d in ce ll s on the periphery of tum or no dul es . Th e prim ary purp ose of this study is to atte mpt to lo- calize in a large numb er of tum ors by aut o radi og raph y foll ow in g a [ 3 H]thymidin e pulse the pro lif erating ce ll po pubti on within no dular B CC . A second purp ose is to demonstrate that the lo- Ma nuscript recei ved Jun e 17, 1985; accepted for publi c:ai on Se ptemb er 17, 1985. S upp orted in part by gra nt s R23 C A 42 153-0 1 fro m th e N ati onal In- stit ut es of Health and A mc ri can Cancer Society grant I N-1 6x. T he opinions or assertions contain ed herein arc rh e private vicw .s o f rhe authors and arc not to be construed as refl ecting the views o f th e Depa rtm ent of De fen se. Re print requests to: Ro na ld E. Grim woo d, M.D., 456 C lin ic Dri ve, Roo m 473 1, Co lumbu s, O hi o 432 10 Ab breviations: B CC: basal ct:ll carcin oma Ll : labeling index h pul se w as in co rp orated prim arily by cells on the periph- ery of tumor no dul es (lab eling indi ces 6-24%) rath er th an by th e ce ll s mor e ce ntr al in tum or no dules (bb e lin g in d ices 0-2% ). Simil ar re s ult s were al so see n when s ampl es of tum or freshly removed from patie nt s we re la bel ed in v itr o. We co nclud e that th e dividin g ce ll s w ithin no dular BCC a re primaril y th e ce ll s at th e ed ges of tum or no dul es a nd th at thi s char ac te risti c is rel ated to th e sl ow, pr og ressi ve, inva s iv e g rowth o fB CC. J I n iles / Derm a10/ 86: 19 1 -194, 1 986 ca ti on of the proliferati ve ce ll population is simila r in BCCs fr es hl y rem ove d from the hum an host and BCCs on the nude mouse. MATEIUALS AND METHODS BCC Tissue Ti ss ue was ob ta ined tro m I() patient s w ith bi opsy - proved nodular BCC who we re under go in g Mobs controlled excision. Th e t um or ti ss ue used for these studi es was the portion of the tum or that wo uld o rd in a ril y be di scarded in the gross debulking of th e tum or prior to stage excision. Th e BCC tum or ti ss ue was trans pbnt cd into s pl enec2o mi zc d nud e mi ce who we re furth er i mm un os u ppr essed with antil y mph ocyte seru rn (MA Bi oproducts, Walkerv ill e, Marybnd ). The deta il s of t hi s tec h- nique ha ve bee n previously described [6[. In 2. cases of large BCCs, a portion of the tum or ti ss ue imm ed iately af ter removal from the pa ti e nt was studied by [ 3 1-!]th ymid in e up ta ke and au- toradi og raphy. Tissue Harvesting Th e gr ow in g nodular l3 CCs on nud e mi ce we re rem ov ed 60 days a ft er tr ansplanta ti on and we re bisected. Half of each specimen was frozen in o ptimum cutting te mp era tur e mountin g medium and was sec ti oned at 4 J..Lm on a cryostar. Sec ti ons we re stained with hemat oxy lin and eos in fo r hi stolog ic confirmation of tho.: BCC. Th e other ha lf was cut into secti ons 1-2 mm thick, and the sec ti ons were in cubated with [ 3 H]thymid in e. Pulse Labeling and Autoradiograph y Portions of th e 2 l:3 CCs remove d from the patient s and the I 0 B CCs removed from the nude mi ce were in cubated in vitro with 2.0 J..L Ci ! 3 H [th y m idin e (New England Nu clea r, NE T-0 27X, 20 C i/ mm ol, 1 Ci = 37G Bq ) in 5 ml of MC DB 15 3 medium (Depa rtm cllt of Molec ubr , Cellular, and Develo pm ent al Biology, University of Co lorado, Boulder, Co lo rad o) . The ti ss ue and the medi a were gently agi- tated in a Petri dish on a shaker in cubator (La b- Line O rbi t En vivo Shaker, Lab-Line In s trum e nt s, In c. , Melrose Park, Illinoi s) for 4 h at 37"C. Fi ve nud e mi ce with BC xc nog raft s we re inj ected i. p. with 50 J..L Ci [ 3 1-ljthymidinc mixed in 0. 5 ml of Hanks' balanced sa lt solution. After 4 h, th e mi ce we re sacrifi ce d, and tum or ti ss ue was excised. 0022-202X/86/$03.50 Co py ri ght © 1986 by The Society for In vestigative Derm atology, In c. 191
4

Proliferating Cells of Human Basal Cell Carcinoma Are ... · asal cell ca rcinomas (BCCs) account for at least 75% of cancer of the skin, the most common sit. e of human cancers,

Aug 20, 2019

Download

Documents

vuongthuan
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Proliferating Cells of Human Basal Cell Carcinoma Are ... · asal cell ca rcinomas (BCCs) account for at least 75% of cancer of the skin, the most common sit. e of human cancers,

Proliferating Cells of Human Basal Cell Carcinoma Are Located on the Periphery of Tumor Nodules

Ronald E . Grimwood, M.D. , Charles F. Ferris, Ph .D ., Donald B . Mcrcill, B.S., and J. C lark Huff, M. D . Dep artm ent o f I crmato logy . Uni ve rsity o f Colo rado (J C I-1) , Denver, Colo rado; I cpartmcnts o f Medi cin e and C lini c:1l In vesti gatio n , Fitzs imo ns Arm y Medica l Center (C FF, DBM) , Au ro ra, Colo rado; and Department o f Med ic ine , O hio Sta te Uni versity (REG) , Columbus, O hio, U. S. A.

S tudy of th e g rowth characte ris ti cs o f basa l cell carcino ma (BCC), a relatively w ell-o rg ani zed, slow-g rowing skin cance r , has been limited because o f the lack o f m ethods fo r propa g ation of the tum o r off the human hos t. We have use d n e wl y d evelo ped techniques for transp lantatio n and propa g ation of B CC on ath y mic mi ce to s tudy e HJthymidine in corporation b y no dubr DCC. In human BCCs labeled in vitro immedi a tely after re m o val fro m the mice and in vivo on the mice , [3Hjth y midine durin g a 4-

B asal cell ca rcino mas (B CCs) account fo r at least 75% of can cer o f th e skin, the mos t comm on sit. e of human can cers, and thus are the mos t common clini ca l-hi s­to logic subset ofhuman malignan cies f I ,2 ]. Although not a cause of signifi cant mortality, BCC does ac­

count for considerable morbidity and fo r signifi cant expenditures of h ealth ca re dollars.

S tud y o fB CC has been hampered by the diffi culties of stud ying a ca ncer on th e hum an host, th e lack o f an animal model , and th e inability to propagate th e tum or in virro . In parti cular, it has no t been poss ible to understand the g rowth cluracteri sti cs of this us u ally well-o rganized , slow ly invas ive, but histo logicall y ma­lig n ant tum or. Previ ously reported attempts to perform autora­d iographi c studies of human BCC have no t presented data that would locali ze the proliferatin g cell s to a parti cular ana to mic area of t he BCC tumor [3-5].

We have recentl y described methods by which hum an BCC may be propagated on th e ath ymic o r nude mouse and have shown th at B CC growin g on the mouse maintains th e histology ofBCC on the human hos t [6]. We also no ted as part of our pilot studies of 4 tum o rs th at [3H ]th ymidine uptake by BCC harvested fro m the nude mouse was not unifo rm throughout th e tum or but was predo minantly localized in ce lls on th e periphery o f tum or nodules . The prim ary purpose o f this stud y is to attempt to lo­cali ze in a large number of tum ors by autoradi og raph y following a [3 H]thymidine pu lse the pro liferatin g cell po pubtion within nodular BCC. A second purpose is to demonstra te th at the lo-

Ma nuscript recei ved June 17, 1985; accepted fo r publi c:aion September 17, 1985.

Suppo rted in part by grants R23 C A 42 153-0 1 fro m the N ational In­stitutes o f Health and A mcri can Ca ncer Society g rant I N-1 6x .

T he opinio ns o r assertions contained herein arc rhe private vicw.s o f rhe a utho rs and arc no t to be construed as refl ectin g the views o f th e Depa rtm ent o f Defen se.

Reprint reques ts to: Ro na ld E. G rim wood, M.D ., 456 C lin ic Dri ve, Roo m 473 1, Columbus, O hio 432 10

Abbreviatio ns: BCC: basal ct:ll carcino ma Ll : labelin g index

h pulse w as incorpo rated prim aril y b y cell s o n the periph­e r y o f tumor n o dules (labe ling indi ces 6-24%) rather th an b y the cell s more centra l in tum o r n o dules (bbeling ind ices 0-2% ). Simila r results w ere also seen w hen samples of tum o r fres hl y re m o ved fro m pa tients were labeled in vitro . W e conclude that the dividing cell s w ithin n o dular BCC are primaril y the cell s a t the ed ges of tum o r n o dul es and tha t this cha racte risti c is rel ated to the slow, progressive, invasive g rowth o fB CC.J I n iles / Derma10/ 86: 19 1-194, 1986

ca tion of the proliferati ve cell population is similar in BCCs freshly removed from the human hos t and BCCs on th e nu de mouse.

MATEIUALS AND M ETH O DS

BCC Tissue Tiss ue was obta ined tro m I() patients w ith biopsy­proved nodular BCC who were und ergoing Mo bs controlled excision. The tum or ti ss ue used fo r these studies was th e po rti on of th e tum or that wo uld o rd in aril y be di sca rded in the gross debulkin g of the tum or prio r to stage excision. The BCC tum or tiss ue was transpbntcd into splenec2omi zcd nude mice w ho were furth er i mm un os u ppressed w ith antil ymphocy te seru rn (MA Bio produ cts, Walkervill e, Marybnd). T he detail s o f thi s tech­nique ha ve bee n prev iously described [6 [. In 2. cases of large BCCs, a porti on of the tum or tiss ue immed iately after remova l from th e patient w as studi ed by [31-!]thymidine up ta ke an d au­to radiograph y .

Tissue Harvesting The growing nodul ar l3 CCs on nude mice were removed 60 days after transplantati on and we re bisected. H alf o f each specimen was frozen in optimum cuttin g tempera ture mounting medium and was secti oned at 4 J..Lm on a cryos tar. Sections were stained with hematoxy lin and eos in fo r hi stologic confirmation o f tho.: BCC. The oth er half was cut into sections 1-2 mm thick, and th e sections were incubated with [3H]th ymidin e.

Pulse Labeling and Autoradiography Porti ons of the 2 l:3CCs removed fro m the pati ents and th e I 0 BCCs removed fro m th e nude mi ce were incubated in vitro w ith 2.0 J..LC i !3H [th ymidin e (New England Nu clea r, NET-027X , 20 C i/ mmol, 1 C i = 37G Bq) in 5 ml of M C DB 153 medium (Departm cllt o f Molecubr, Cellular, and Developmental Bio logy, Uni versity of Colorado, Bould er, Colo rado) . T he tiss ue and the medi a were gently agi­tated in a Petri dish on a shaker in cuba to r (La b-Line O rbi t En vivo Shaker, Lab-Line Instruments, In c. , Melrose Park, Illinois) for 4 h at 37"C.

Fi ve nude mice w ith BC xcnografts we re injected i. p. w ith 50 J..LC i [31-ljthymidinc mi xed in 0. 5 ml of Hanks' ba lanced sa lt solution. After 4 h, th e mi ce we re sacrifi ced, and tumor ti ssue was excised.

0022-202X /86/$03.50 Co pyright © 1986 by The Society fo r In vestigati ve Derm ato logy, In c.

191

Page 2: Proliferating Cells of Human Basal Cell Carcinoma Are ... · asal cell ca rcinomas (BCCs) account for at least 75% of cancer of the skin, the most common sit. e of human cancers,

192 GHIMWOOD ET A I.

Figure 1. A pho to micrograph of a s tained s~ct i o n o f a UCC after rcntova l fro m the pati~nt (original nugnificarion X 125). The section d~mon s tra tcs solid mass~s of tum or cells and pallisadcd nucle i at the edge of tumo r masses .

After th e 4-h pulse, the J3 CC tissue fro m bo th the in vitro and in vivo labelin g ex perim ents was fi xed for 4 h in Tcll y's fi xa ti ve, rinsed in tap wa ter fo r 12 h, and embedded in paraffin. The ti ss ue was then sectioned at 5 J.llll through the center o f the tum o r nodules, and secti ons were placed on mi croscope sli des and w ere deparaffinized . T he sectio ns were dipped in a solution of Kodak N BT-2 emulsion , diluted I: 1 w ith distil led water, and we re ex­posed in li ght-ti ght boxes fo r 7 da ys at 4°C. The emulsion was

Figure 2. 1\ photomicrograph of a stained section of the same l3CC as in Fig I after remova l from a nude mouse 60 days after transpbntation (orig inal magnifi ca tio n X 250). T he same hi stOlogic fea tures of l3CC present pri or to tra nsplantation arc pres~nt after remova l front the nude rn ousc.

T H E JOURNAL O F INV ESTIGAT IV E I ERMATO LOGY

Figure 3. A photomicrograph o f a sect ion of a B C rcmov~d fro m a nude mo use afte r in-vitro labeling w ith 1-' H I th y midine, auto radiog raph y. and staining (orig inal magnifi cation x 250). Labeled nu clei arc present pr~dominantl y on th e pcriph~ry of tum or nodules, and fe w la bckd nuclei arc present centra ll y.

deve lo ped w ith Kodak D-19 and fixed with Kodak fixer. The s<.:c ti o ns were th en countcrstained w ith hematoxylin and eosin .

Exarnination of Labeled Sections Labeled cells were defm ed as well-identified tumor cell s with 3 or m o re silver g rains over th e nuclei, and w ith a backg round of less than I g rain per cel l. For each tum o r nod ule, a labe li ng index (LI) was determined for the peripheral cells (outer 5 cell laye rs) and th e central cells. In each zone of a BCC no du le, 200 cell s were counted. Li s were calculated as the number o f labeled cells per 200 cells.

RESULTS

Light Microscopy of Frozen BCC Specimens The light­mi crosco pi c scction s of frozen J3CC tissue, both immediately aftcr harvest from patients and rem ova l from nude mi ce, gave good mo rph olog ic detail consistent w ith solid BCC. Fig l illus­trates the morph o logy of a solid BCC prior to transplanta tion into thc nude m o use, w hile Fig 2 depi cts the sa m e tumor harvested fro m the nude m ouse 60 da ys later. Typica l histo lo gic fea tures of so li d J3 CC no ted in clude uniform masses o f tumor cells with a cell la yer on the periphery o f the tumor in which nuclei assume a pallisade arran gement. In all 10 tum o rs, the initi al morphology was m aintai ned after transplantation .

Autoradiography Res ults of autoradiography performed on the 10 BCCs pul se-labeled in vitro after rem ova l from nude mice arc illu strated in Fi g 3. After a 4-h pu lse with [31-! Jthymidine, labeled nuclc.:i were pr~scnt predo minantl y o n the periphery of the tum or masses . B y far the m aj o rity of th e cells that took up th<.: label were w ithin th e mos t p<:ripheral cell layer o f th e tum or, the la yer with th e pa ll isadcclnu clei . However, labeled nuclei were also no ted in cells inside the m ost periphera l la yer. Labeling in­dexes (Table I) for tumor cells in the o utermost 5 cell la yers ,

Table I. Ll of Basal Cell Ca rcinom as

Ll % lm ean and (range)]

Labeling Number Peripheral Central Tumor Method Studied Cells Cells

UCCs removed fro m In vitro 10 17.4% 0.3% nude mice ( 11 -24) (0-1 )

In vivo 5 8.8% 1.0% (6- 13) (0- 2)

BCCs freshl y rem oved In vitro 2 II % 1.2% fro m patien ts (10-1 2) (0- 2)

Page 3: Proliferating Cells of Human Basal Cell Carcinoma Are ... · asal cell ca rcinomas (BCCs) account for at least 75% of cancer of the skin, the most common sit. e of human cancers,

VO L . 86. N O.2 FEUi tU AH Y 19H6

in cludin g th e peri phera l pallisadcd b ye r, exceeded those of cell s in the ccmral po rtio n of th e rum o r ( 17'Yo vs less th an I %) .

Similar findin gs w ere no ted fo r the 2 tum o rs bbc led in v it ro immedia tel y a fte r rem ova l fro m pati cnrs (Fig 4). It is no t poss ib le to a tta ch an y sif!; nifi ca nce to th e sma ll diffen:nces in Li s between th e tumo rs harves ted fro m patients and th ose rem oved ti·om nud e mice (Table 1).

In the 5 UCC tum o rs labe led in vivo in th e nud e mi ce. differ­enti a l labelin g between pe riphe ra l ce lls and central cell s in th e rum o r was aga in seen (Fig 5) . T he lo w er Li s fo r th e periphera l cell s compared w ith th ose o btain ed in v itro (T able I) m ay be du e to the i . p. ad ministrati on of [-' H] thy tni d ilH: and the fac t th at th e cun1 o r cells were exposed to a mu ch lower concentration of th e Ia belcd nu cleotide.

DISC U SS IO N

O ur m aj o r conclusio ns fro m auto radi og raphi c stu dy o f hum an BCCs ha rv es ted fro m nude mi ce arc th at th e pro life ratin g cell po pulatio n w ithin tum o r nodu les is no t unifo rml y di stributed thro u g ho ut the rumor and that the cell s sy nthes izin g DNA arc loca ted predo minantl y on the periphe ry o r the tumo rs . A lth oug h rh e lar ges t number o f labeled nu clei w as seen along the m ost peripheral cell layer w ith pallisadcd nu clei , m an y labeled nu clei wer e also seen in the several cell b ye rs in sid e the mos t periphera l laye r. Wh en th e Li s o r the outerm os t 5 cel l layers of tum o r no dules we r e co mpared with th ose of cells loca ted in the central portio ns, ap p rox im ately 10-fo ld di fferences w ere seen . T his findin g docs no t nega te th e poss ibility th at so me cells located cen t ral ly arc ca p a ble o f DNA sy nth esis; in fact , a Ll of up to 2% w as seen fo r these cell s . However, th e t rem end o us diffe rences in Li s th at we no te d between the 2 zo nes o f B CC nodules wo uld impl y that m os t of the dividin g ce lls arc located in the o uterm os t ce ll b yers of the no du les.

With the in-v ivo pu lse labelin g of BCCs. it mi ght be argued ch a t the m os t periph era l cells in th e tum o rs were ex posed to hig her con centratio ns o f \31-1 \th ymidin e and that this mi ght expl ain th e

Figure 4. A ph oto micrograph of a section of a l3CC that w:1 s 13bekd in vitro immediately after removal fro m the paticnt (o rigin :tl magnitica tion X 250). Labeled nuclei arc located largel y in the cells at the periphery of rumor nodules. T he labeling characteristi cs of 13 Cs removed fro m nude mice (Fig 3) arc similar to the characteristi cs noted for l3CCs removed fro m patients.

BASAL CELL CA itCINOM A 193

di ffe rences in Li s. H oweve r, o ur fin d in g of even m o re st riking d ifferen tia ls in Li s in 13CCs in cubated in vit ro in \31-lJthy midine would sugges t th at the diftc rcnccs arc valid. With th e in-vitro labelin g o f th in sectio ns through tum o r nodules, th e m o re pe­riph eral cell s and the central cells w ere ex posed to similar co n­cen trati ons of the labeled nu cleotide. We think that these res ults th ere fo re refle ct tru e differences in the pro life rati ve characte ri stics o f ce lls in different zo nes of nodular 13 C

An o th er m aj o r co nclu sio n is th at the zo nal di st ri butio n o f pro­liferatin g ce lls no ted fo r BCCs harves ted fro m nude mi ce refl ec ts a charac te risti c also seen w ith tum o r immedi atel y after rem ova l fro m th e hum an host . T he 13CCs stud ied immed iately after re­mova l fro m patien ts gave results q ui te simila r to th ose seen w ith BC s removed ti·o m nu de mi ce.

It is d ifficul t to ascer tain rro m previously pu blished stu d ies o f hum :1 n BCC w hether a similar zona l d istribu tion of pro life ratin g ce lls has been no ted. Weinstein and Fros t \31 it ~ccted J31-llth ymidin e in to UCCs on patients and dete rmin ed the duratio n o f the cell cycle fo r th e tum o r cells. As part o f this stud y. Lis afte r 30- to nO- min pu lses were reported to va ry between 5-13%. In this study th e invcsti!-';a to rs studi ed selected. we ll -labeled sm all island s o f tum o r w hi ch ~eem ed to show a unifo rm distributio n o fl abcled nu clei . Specifica ll y excluded were specimens th at did no t show a uniform d istributi o n of l:tbelcd nu clei . Perhaps in this stud y sec­ti ons thro ug h the peripheral po rtio n of tum o r nodules, rather than thro ug h the entire tum o r nodules, were stud ied. These in­vest igato rs considered that .BCCs consisted of a relati vely ho­m ogcneo u · po pulati on of pro liferati ve ce ll s.

In :1 second stu dy repo rr ::d by H eenen et al 14] BCCs pul se­label ed in vitro to r I 5 m in produ ced Li s of8- l 0% . These auth o rs state th at labeled nu clei we re lo un d onl y in " periphe ral zo nes o f tum or fra g ments," and th ey the refo re rest ric ted their stud y to the periph ery o f S:l mpl es w he re labeli ng was un ifo rm . Perhaps th ese in vestigato rs also studied the m o re peri pheral cells o f nee and specift cal\ y exclu ded the m o re central cells o f tum o r nodulc::s.

In a thi rd stud y f-' HJth y midin e was infused imo a pati ent w ith BCC fo r 14 days J5 J. T he L1 rose fro m 12.5% at 2 h w 80% at

Figure 5. A photomicrograph of a section of BCC labeled in vivo on the nude mouse {original magnifi ca tion x 250). Most labeled nuclei arc present in the outermost ce ll layers of the BCC.

Page 4: Proliferating Cells of Human Basal Cell Carcinoma Are ... · asal cell ca rcinomas (BCCs) account for at least 75% of cancer of the skin, the most common sit. e of human cancers,

194 GWMWOOD ET AL

14 days. N o specifi c details were given rega rdin g w here, w ithi n the tum o r, sectio ns were taken and counts made.

C lini cians have lo ng recognized that B CCs arc ver y slow­gro win g tumors 11 ,3] and ma y require months to yea rs to double in size. T his fa ct makes it diffi cult to accept that all the cell s w ithin a BCC are undergoing cell division at an equal rate, even if the cell cycle is relati vely long and similar to that o f basa l cells of the no rmal epidermis 13] . Beca use g rowth of a tum o r represents an excess of cell production over cell loss, the discrepancies between th e clini call y observed g rowth charac teristi cs and th ose reported fro m experimental studies ha ve been expla ined by a hi g h rate of cell dea th in BCC [4] . It is clear that histopatho logica ll y regressive changes such as stell ar atroph y, pseudo cys t and hcunae fo rm a­tion , and cy lindro matous degeneration are seen within BCC j7]. Apoptosis of tumor cells, as evidenced by colloid bodies, and crea tion o f am ylo id-like mate ri al from remnants o f necro tic tu­mor cells arc now well recognized [8-10]. The res ults of our stud y would suggest th at, in add itio n to cell death and a relativel y long cell cycl e, another ex planation for the observed slow g rowth of BCC is that a large portion of the cells within the tumor nodules, specifi ca ll y the central cells , is not actively proliferating .

T he reason for the zonal distribution of proliferating cel ls within nod ular BCC is not apparent. O ne ex planation mi ght be th at the proliferative ca pability of tumor cells in the no dules decreases progressively from th e peripher y to the center due to ph ysiologic factors, such as .a diminished ava ilability o f nutrients for m o re central cell s, w hi ch arc most distant from the s tro ma and the vascubr supply . . Another poss ible cxaplanation might be that tum or cells move from th e periphery of the tumor nodules to th e center and undergo a type of differentiation th at is similar to normal epithelial cell s. Along with the movement into a "diffe r­entiating" compartment of cell s wou ld co me a diminished po­tential for division.

T wo practi ca l impli ca tions of o ur fi ndin gs rel ate to attempts to culture in vitro th e cells of BCC and to the therapy of the tumor. We and others have ex perien ced diffi culty pro paga tin g in tissue culture the cell s o f a BCC. Part of this diffi culty ma y be du e to the fact tlut a large percentage of th e cel ls of a nee proliferate slowly o r not at all, as indica ted by o ur findin gs .

'T'I-IE JOU RNAL O F INVESTIGATI VE DE itMATOLOGY

C lini cians have lo ng emphasized the necess ity of remo ving all nodular ex tensio ns fro m a BCC for success ful sur g ica l therapy of the tumor. If, in fac t, these ex tensions o n the periphery of a nodu lar UCC possess th e most act ively dividin g cells o f the tu­m o r, the importance of remo val o f th e periph era l po rti ons of the tumor wou ld be quite understand able.

In conclusion , we think that the ability to pro paga te hum.an BCC on the nude mouse w ill faci litate future attempts to better understand the g row th o f BCC and w ill allow future studi es that arc no t poss ibl e on the human hos t.

RE FEREN CES

I . Po llack SV, Goslcn JB , Shcn:rtz EF, J cgaso th y 13V: The bio logy of basal cell carcino ma: a rev iew. J Am Acad Derm ato l 7:569-577 , 1982

2. H aenszd W: Variations in skin cancn incidence.: w ithin the United States. Natl Can cer Inst Monogr 10:225-243, 1963

3. Weinstein G D, Fros t P: Cell pro li feratio n in hum an basal ce ll car­cino ma. Cancer Res 30:724-72H, IY7()

4. Hcencn M , Achto n G. Ga rland 1' : Auto r:1 diographi c ana lys is of all kineti cs in hum an no rmal epidermi s and basal cell ca rcino m a. Ca ncer rl.cs 33: 123- 127, 1973

5. T crzJL. Law rence W, Cox 13: Ana lysis of the cyclin g and no ncycling ce ll popubtion of human solid tum ors. Cancer 40:1462- 1470, l977

6. G rim wood RE, j ohnson C A, Ferris CF, Mcrcill Dl3, Mellette J R, HuffJ C : Transplantation of human basa l cell ca rcino m:1s to athymic rn1 ce, in press

7. Kint A: Patho logy o f basa l cell epitheli o ma , Cance r of the Skin. Edited by H.G Andrade, SL Gumport, GL Po pkin , ct al. WB Saunders, Philadelphia , 1976, pp 845-882

8. Weedon D, Shan d E: Am ylo id in basa l cell c 1rcino mas. Br J D er­ma to l 101:1 41- 146, 1979

9. Hashimoto K , Koba yashi 1-1 : Histogenesis o f amylo id in the skin. Am J Dcrmato patho l 2: 165- '171, 1980

10. H ashim oto K, Brownstein MI-l : Locali zed amylo id os is in basal cell ep ithelio ma. Acta Dcrm Vcnerco l (Stockh) 53:33 1-339, 1973